Back to 
Federated Hermes, Inc.
Federated Hermes, Inc.
TRVI
7 quarters
Position history for Federated Hermes, Inc.'s holdings in Trevi Therapeutics, Inc.
No. Federated Hermes exited its TRVI (Trevi Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 598 shares worth $1,997. Federated Hermes first reported TRVI in Q3 2022 and held it in 5 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1,000
Total Shares Change
-872
Quarter-by-Quarter History
Other major holders of TRVI: FMR LLC, BlackRock, Inc., Wellington Management Group LLP